DENDRITIC AND T CELLS IN ANTI-BACTERIAL lg RESPONSES
DENDRITIC AND T CELLS IN ANTI-BACTERIAL lg RESPONSES
批准号:
7782763
负责人:
CLIFFORD M SNAPPER
金额:
$32.15万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-04-01 至 2012-03-31
关键词:
Adoptive TransferAnti-Bacterial AgentsAntibodiesAntigensB-Lymphocyte SubsetsB-LymphocytesBacteriaBacterial PolysaccharidesBacterial ProteinsBacterial VaccinesBindingCD4 Positive T LymphocytesCD40 LigandCell SeparationCell WallCellsCharacteristicsDataDendritic CellsDevelopmentElectronicsEmployee StrikesEnzyme-Linked Immunosorbent AssayExhibitsFoundationsFundingGenerationsGoalsHumoral ImmunitiesImageImmuneImmunityImmunizationImmunoglobulin GImmunoglobulin MImmunoglobulinsImmunologic MemoryImmunologicsIn SituIn VitroKineticsKnock-in MouseLightMediatingMemoryMicroscopicMorbidity - disease rateNaturePhysiologicalPlayPneumoniaPolysaccharidesPopulationProblem SolvingProductionProteinsReceptor SignalingReceptors, Antigen, B-CellRecruitment ActivityRelative (related person)ResearchRoleSerotypingSignal TransductionSpecificitySpeedSpleenSplenic TissueStreptococcus pneumoniaeT cell responseT-LymphocyteTestingTextTimeTransgenic MiceTransgenic OrganismsVaccinesWild Type Mouseadaptive immunityanti-IgGbasecell typedesignenzyme linked immunospot assayextracellularfunctional statusimprovedin vivoinsightmortalitynovelpathogenpneumococcal surface protein Aresponsespatiotemporal
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Streptococcus pneumoniae (Pn)is an extracellular bacterium that is a major cause of global morbidity
and mortality. Systemic adaptive immunity to Pn is mediated by antibody, especially IgG specific for the
capsular polysaccharide (PS),but also for bacterial proteins. Our long-term goal is to elucidate the
cellular mechanismsthat underlie the distinct differences that exist between in vivo anti-PSand
anti-protein Ig responses to intact Pn, as a prerequisite to the development of improved vaccines.In
contrast to the current dogma, based on using purified PS antigens, that IgG anti-PS responses are T
cell-independent, we demonstrated that the IgG anti-PS response to intact Pn is heavily dependent on CD4+
T cells but nevertheless, still exhibits striking differences in kinetics, generation of memory, and the
functional roles of dendritic and T cells relative to the co-induced anti-protein response. In light of these
data, the central hypothesis that underlies our proposed research is that differential B cell receptor
signaling and/or involvement of functionally distinct B cell subsets are the key parametersthat
distinguish physiologic anti-PS and anti-protein Ig responses. We will demonstrate that these
parameters differentially impact on 1) the temporal compartmentalization of responding B cells within the
spleen, and 2) the cellular interactions of the responding B cells with other immune cell types. As a result we
will provide a mechanistic basis that will elucidate the observed differences in anti-PS and anti-protein
responses. The specific aims are to:
1. Determine the nature and relationships of B cell and dendritic cell subsets, and CD4+ T cells that
differentially mediate in vivo anti-PS and anti-protein Ig isotype responses to systemic immunization
with intact Pn. We will utilize high speed electronic cell sorting and adoptive transfer of wild-type and
genetically altered immune cells combined with ELISPOT and ELISA analyses of antigen-specific Ig isotype
production to accomplish thisaim.
2. Determine the mechanism by which B cells, DCs,and CD4+ T cells differentially orchestrate
anti-PS and anti-protein responses within a spatiotemporal context. We will utilize B cells from BCR
knock-in mice with Ig specificity for Pn-derived PS or protein antigens and T cells from CD4+ TCR
transgenic mice with specificity for a Pn-derived protein to accomplish this aim.These cells will be used to
conduct in vitro functional studies and confocal microscopic analyses of splenic tissue sections
post-immunization. These studies are the first to systematically determine the mechanisms that
distinguish anti-PS from anti-protein responses to an intact bacterium and provide novel basic
immunologic insights with direct relevanceto the development of anti-bacterial vaccines.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.4049/jimmunol.1502709
发表时间:
2016-05-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Saumyaa, Pujanauski L, Colino J, Flora M, Torres RM, Tuomanen E, Snapper CM]
通讯作者:
Snapper CM
DOI:
10.4049/jimmunol.181.12.8258
发表时间:
2008-12-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Chen Q, Cannons JL, Paton JC, Akiba H, Schwartzberg PL, Snapper CM]
通讯作者:
Snapper CM
The critical DNA flanking sequences of a CpG oligodeoxynucleotide, but not the 6 base CpG motif, can be replaced with RNA without quantitative or qualitative changes in Toll-like receptor 9-mediated activity.
CpG 寡脱氧核苷酸的关键 DNA 侧翼序列(但不是 6 碱基 CpG 基序)可以用 RNA 替换,而不会导致 Toll 样受体 9 介导的活性发生量或质的变化。
DOI:
10.1016/j.cellimm.2005.01.010
发表时间:
2004
期刊:
Cellular immunology.
影响因子:
--
作者:
[Sen,Goutam, Flora,Michael, Chattopadhyay,Gouri, Klinman,DennisM, Lees,Andrew, Mond,JamesJ, Snapper,CliffordM]
通讯作者:
Snapper,CliffordM
DOI:
10.3389/fimmu.2018.00598
发表时间:
2018
期刊:
Frontiers in immunology
影响因子:
7.3
作者:
[Snapper CM]
通讯作者:
Snapper CM
DOI:
10.1002/eji.201344266
发表时间:
2014-05
期刊:
EUROPEAN JOURNAL OF IMMUNOLOGY
影响因子:
5.4
作者:
[Colino, Jesus, Duke, Leah, Snapper, Clifford M.]
通讯作者:
Snapper, Clifford M.
共 6 条
(Poly)glycerolphosphate-based, cross-protective anti-staphylococcal vaccine
-
批准号:8074028
-
项目类别:
-
资助金额:$22.72万
-
财政年份:2010
-
负责人:CLIFFORD M SNAPPER
-
依托单位:
(Poly)glycerolphosphate-based, cross-protective anti-staphylococcal vaccine
-
批准号:7963436
-
项目类别:
-
资助金额:$19.13万
-
财政年份:2010
-
负责人:CLIFFORD M SNAPPER
-
依托单位:
GP350 AS A NOVEL VACCINE PROTEIN CARRIER
-
批准号:7958394
-
项目类别:
-
资助金额:$6.49万
-
财政年份:2009
-
负责人:CLIFFORD M SNAPPER
-
依托单位:
GP350 AS A NOVEL VACCINE PROTEIN CARRIER
-
批准号:7562069
-
项目类别:
-
资助金额:$10.36万
-
财政年份:2007
-
负责人:CLIFFORD M SNAPPER
-
依托单位:
Novel Carrier for Polysaccharide Conjugates and an EBV Vaccine
-
批准号:7537173
-
项目类别:
-
资助金额:$23.09万
-
财政年份:2007
-
负责人:CLIFFORD M SNAPPER
-
依托单位:
Novel Carrier for Polysaccharide Conjugates and an EBV Vaccine
-
批准号:7388052
-
项目类别:
-
资助金额:$19.24万
-
财政年份:2007
-
负责人:CLIFFORD M SNAPPER
-
依托单位:
GP350 AS A NOVEL VACCINE PROTEIN CARRIER
-
批准号:7349607
-
项目类别:
-
资助金额:$3.5万
-
财政年份:2006
-
负责人:CLIFFORD M SNAPPER
-
依托单位:
DENDRITIC AND T CELLS IN ANTI-BACTERIAL lg RESPONSES
-
批准号:7219524
-
项目类别:
-
资助金额:$33.1万
-
财政年份:2001
-
负责人:CLIFFORD M SNAPPER
-
依托单位:
DENDRITIC AND T CELLS IN ANTI-BACTERIAL Ig RESPONSES
-
批准号:6317430
-
项目类别:
-
资助金额:$25.94万
-
财政年份:2001
-
负责人:CLIFFORD M SNAPPER
-
依托单位:
DENDRITIC AND T CELLS IN ANTI-BACTERIAL Ig RESPONSES
-
批准号:6870301
-
项目类别:
-
资助金额:$25.94万
-
财政年份:2001
-
负责人:CLIFFORD M SNAPPER
-
依托单位:
DENDRITIC AND T CELLS IN ANTI-BACTERIAL Ig RESPONSES
-
批准号:6511325
-
项目类别:
-
资助金额:$25.94万
-
财政年份:2001
-
负责人:CLIFFORD M SNAPPER
-
依托单位:
DENDRITIC AND T CELLS IN ANTI-BACTERIAL lg RESPONSES
-
批准号:7388292
-
项目类别:
-
资助金额:$32.47万
-
财政年份:2001
-
负责人:CLIFFORD M SNAPPER
-
依托单位:
DENDRITIC AND T CELLS IN ANTI-BACTERIAL lg RESPONSES
-
批准号:7590402
-
项目类别:
-
资助金额:$32.47万
-
财政年份:2001
-
负责人:CLIFFORD M SNAPPER
-
依托单位:
DENDRITIC AND T CELLS IN ANTI-BACTERIAL Ig RESPONSES
-
批准号:6711764
-
项目类别:
-
资助金额:$25.94万
-
财政年份:2001
-
负责人:CLIFFORD M SNAPPER
-
依托单位:
DENDRITIC AND T CELLS IN ANTI-BACTERIAL lg RESPONSES
-
批准号:7103213
-
项目类别:
-
资助金额:$34.09万
-
财政年份:2001
-
负责人:CLIFFORD M SNAPPER
-
依托单位:
DENDRITIC AND T CELLS IN ANTI-BACTERIAL Ig RESPONSES
-
批准号:6632308
-
项目类别:
-
资助金额:$25.94万
-
财政年份:2001
-
负责人:CLIFFORD M SNAPPER
-
依托单位:
B7 COSTIMULATION RESPONSE TO EXTRACELLULAR BACTERIA
-
批准号:6031880
-
项目类别:
-
资助金额:$8.59万
-
财政年份:2000
-
负责人:CLIFFORD M SNAPPER
-
依托单位:
B7 COSTIMULATION RESPONSE TO EXTRACELLULAR BACTERIA
-
批准号:6374375
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2000
-
负责人:CLIFFORD M SNAPPER
-
依托单位:
B7 COSTIMULATION RESPONSE TO EXTRACELLULAR BACTERIA
-
批准号:6734731
-
项目类别:
-
资助金额:$39.1万
-
财政年份:2000
-
负责人:CLIFFORD M SNAPPER
-
依托单位:
B7 COSTIMULATION RESPONSE TO EXTRACELLULAR BACTERIA
-
批准号:6192814
-
项目类别:
-
资助金额:$26.73万
-
财政年份:2000
-
负责人:CLIFFORD M SNAPPER
-
依托单位:
海外基金